Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges
Analytical Chemistry · 03.03.2026 · 98 (8) · 5828-5842
DOI: 10.1021/acs.analchem.5c06531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Analytical Chemistry, online erschienen am 19.02.2026. Verfasst von Sunil Kumar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy. Hauptthemen laut MEDLINE: Antibodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
Polyclonal antibodies (pAbs) are a cornerstone of the adaptive immune system, providing broad-spectrum protection by recognizing and neutralizing diverse antigens. Intravenous immunoglobulins (IVIg) derived from animal/human plasma are widely used to treat diseases such as primary immunodeficiencies, autoimmune neurological disorders, and situations requiring rapid immune protection, such as emerging infectious disease outbreaks. Compared with monoclonal antibodies (mAbs), pAbs offer several advantages, including faster, less technically demanding, and more cost-effective production, often directly from immunized animals or human serum. However, their complex, heterogeneous nature─reflecting the polyclonal response to multiple epitopes─creates significant challenges for characterization, quality control, and regulatory approval. pAbs have been underutilized in therapeutic applications due to the absence of robust, standardized analytical tools capable of fully assessing their heterogeneity. Conventional chromatographic and spectroscopic methods yield limited qualitative and quantitative information, insufficient for detailed structural and functional evaluation. This perspective highlights recent advances in high-resolution analytical technologies, particularly chromatographic and mass spectrometric approaches, that enable in-depth characterization of critical quality attributes (CQAs) of pAbs. These analytical strategies facilitate the assessment of parameters such as structural integrity, molecular size distribution, subclass composition, and polyclonality, which are crucial for ensuring product quality. Alongside these technical developments, regulatory frameworks for pAb-based therapeutics are evolving, emphasizing the need for standardized analytical criteria to ensure safety, efficacy, and batch-to-batch consistency. In our view, by integrating new analytical capabilities with clear regulatory expectations, pAbs can be more effectively developed as therapeutic agents, complementing mAbs and expanding the range of immunoglobulin-based interventions in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
ORCID-Profile: Sunil Kumar, Enrica Calleri
Förderung
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
Kumar, S., Tini, A., Tengattini, S., Rinaldi, F., Calleri, E., Massolini, G., & Temporini, C. (2026). Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges. Analytical Chemistry, 98(8), 5828-5842. https://doi.org/10.1021/acs.analchem.5c06531
Vancouver
Kumar S, Tini A, Tengattini S, Rinaldi F, Calleri E, Massolini G, et al. Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges. Analytical Chemistry. 2026;98(8):5828-5842. doi:10.1021/acs.analchem.5c06531
BibTeX
@article{Kumar2026,
author = {Kumar, Sunil and Tini, Aurora and Tengattini, Sara and Rinaldi, Francesca and Calleri, Enrica and Massolini, Gabriella and Temporini, Caterina},
title = {Polyclonal Antibody Therapeutics: Analytical Innovations and Regulatory Perspectives for Addressing Heterogeneity Challenges},
journal = {Analytical Chemistry},
year = {2026},
volume = {98},
number = {8},
pages = {5828--5842},
doi = {10.1021/acs.analchem.5c06531}
}
EUVIMED